evidence table

Whey Protein Satiety Randomized Trial Evidence Table

Structured evidence table for Whey Protein Satiety Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Whey Protein Satiety Randomized Trial2016 2020 2019 2025 2023 2024 2019 2019 2019 2024 2019 Accelerated global population aging has made the progressive decline in skeletal muscle mass and associated physical functional deterioration among older adults a major public health concern.2Huijing Bai (2026)The Impact of Oral Whey Protein and Yeast Protein Supplementation for 6 Months on Skeletal Muscle Mass, Strength, and Function in the Elderly: A Randomized, Controlled, Parallel Study
Whey Protein Satiety Randomized TrialFor instance, a UK study found that dynapenia (a key component of sarcopenia) was associated with markedly increased healthcare and social care costs, with annual additional medical expenses attributable to muscle weakness reaching £2.5 billion (Bruyère et al. ).2Huijing Bai (2026)The Impact of Oral Whey Protein and Yeast Protein Supplementation for 6 Months on Skeletal Muscle Mass, Strength, and Function in the Elderly: A Randomized, Controlled, Parallel Study
Whey Protein Satiety Randomized TrialThis study is expected to provide scientific evidence for optimizing protein supplementation strategies in this population.2Huijing Bai (2026)The Impact of Oral Whey Protein and Yeast Protein Supplementation for 6 Months on Skeletal Muscle Mass, Strength, and Function in the Elderly: A Randomized, Controlled, Parallel Study
Whey Protein Satiety Randomized TrialOf particular concern is that sarcopenia substantially elevates healthcare expenditures and overall medical burden (Darvishi et al. ).2Huijing Bai (2026)The Impact of Oral Whey Protein and Yeast Protein Supplementation for 6 Months on Skeletal Muscle Mass, Strength, and Function in the Elderly: A Randomized, Controlled, Parallel Study
Whey Protein Satiety Randomized TrialTheir increasing prevalence has been strongly associated with the presence of multiple cardiometabolic risk factors—including elevated systolic blood pressure, high low-density lipoprotein cholesterol (LDL-c), elevated body mass index (BMI), and elevated fasting glucose—often exacerbated by unhealthy lifestyle behaviors such as physical inactivity and poor dietary habits [].4Tavares Isabela Ribeiro Grangeira (2026)Resistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review
Whey Protein Satiety Randomized TrialAccording to the World Health Organization (WHO), these risk factors are interrelated and play a key role in the development of non-communicable diseases (NCDs), particularly cardiovascular diseases.4Tavares Isabela Ribeiro Grangeira (2026)Resistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review
Whey Protein Satiety Randomized TrialAmong them, elevated systolic blood pressure stands out as the leading modifiable risk factor for premature cardiovascular deaths worldwide, accounting for more than 10 million deaths globally in 2021 [,].4Tavares Isabela Ribeiro Grangeira (2026)Resistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review
Whey Protein Satiety Randomized Trial1 2 3 3 4 Cardiometabolic diseases such as type 2 diabetes mellitus (T2DM), hypertension, obesity, and dyslipidemias rank among the leading causes of morbidity and mortality worldwide, representing one of the most significant challenges to contemporary public health [,].4Tavares Isabela Ribeiro Grangeira (2026)Resistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review
topicWhey Protein Satiety Randomized Trial
claim2016 2020 2019 2025 2023 2024 2019 2019 2019 2024 2019 Accelerated global population aging has made the progressive decline in skeletal muscle mass and associated physical functional deterioration among older adults a major public health concern.
evidence level2
citationHuijing Bai (2026)
sourceThe Impact of Oral Whey Protein and Yeast Protein Supplementation for 6 Months on Skeletal Muscle Mass, Strength, and Function in the Elderly: A Randomized, Controlled, Parallel Study
topicWhey Protein Satiety Randomized Trial
claimFor instance, a UK study found that dynapenia (a key component of sarcopenia) was associated with markedly increased healthcare and social care costs, with annual additional medical expenses attributable to muscle weakness reaching £2.5 billion (Bruyère et al. ).
evidence level2
citationHuijing Bai (2026)
sourceThe Impact of Oral Whey Protein and Yeast Protein Supplementation for 6 Months on Skeletal Muscle Mass, Strength, and Function in the Elderly: A Randomized, Controlled, Parallel Study
topicWhey Protein Satiety Randomized Trial
claimThis study is expected to provide scientific evidence for optimizing protein supplementation strategies in this population.
evidence level2
citationHuijing Bai (2026)
sourceThe Impact of Oral Whey Protein and Yeast Protein Supplementation for 6 Months on Skeletal Muscle Mass, Strength, and Function in the Elderly: A Randomized, Controlled, Parallel Study
topicWhey Protein Satiety Randomized Trial
claimOf particular concern is that sarcopenia substantially elevates healthcare expenditures and overall medical burden (Darvishi et al. ).
evidence level2
citationHuijing Bai (2026)
sourceThe Impact of Oral Whey Protein and Yeast Protein Supplementation for 6 Months on Skeletal Muscle Mass, Strength, and Function in the Elderly: A Randomized, Controlled, Parallel Study
topicWhey Protein Satiety Randomized Trial
claimTheir increasing prevalence has been strongly associated with the presence of multiple cardiometabolic risk factors—including elevated systolic blood pressure, high low-density lipoprotein cholesterol (LDL-c), elevated body mass index (BMI), and elevated fasting glucose—often exacerbated by unhealthy lifestyle behaviors such as physical inactivity and poor dietary habits [].
evidence level4
citationTavares Isabela Ribeiro Grangeira (2026)
sourceResistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review
topicWhey Protein Satiety Randomized Trial
claimAccording to the World Health Organization (WHO), these risk factors are interrelated and play a key role in the development of non-communicable diseases (NCDs), particularly cardiovascular diseases.
evidence level4
citationTavares Isabela Ribeiro Grangeira (2026)
sourceResistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review
topicWhey Protein Satiety Randomized Trial
claimAmong them, elevated systolic blood pressure stands out as the leading modifiable risk factor for premature cardiovascular deaths worldwide, accounting for more than 10 million deaths globally in 2021 [,].
evidence level4
citationTavares Isabela Ribeiro Grangeira (2026)
sourceResistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review
topicWhey Protein Satiety Randomized Trial
claim1 2 3 3 4 Cardiometabolic diseases such as type 2 diabetes mellitus (T2DM), hypertension, obesity, and dyslipidemias rank among the leading causes of morbidity and mortality worldwide, representing one of the most significant challenges to contemporary public health [,].
evidence level4
citationTavares Isabela Ribeiro Grangeira (2026)
sourceResistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review

Learn next

Related evidence and supplement guides

GuideWhey Protein Recovery Randomized Trial: What the Evidence SaysWhey Protein Recovery Randomized Trial has 1 source documents in the current Migaku evidence dat...GuideWhey Protein Muscle Recovery Randomized Trial: What the Evidence SaysWhey Protein Muscle Recovery Randomized Trial has 2 source documents in the current Migaku evide...GuideProtein Satiety Randomized Trial: What the Evidence SaysProtein Satiety Randomized Trial has 2 source documents in the current Migaku evidence database....GuidePea Protein Satiety Randomized Trial: What the Evidence SaysPea Protein Satiety Randomized Trial has 2 source documents in the current Migaku evidence datab...AnswerDoes Whey Protein Recovery Randomized Trial work?Whey Protein Recovery Randomized Trial has evidence relevant to strength of evidence and what th...AnswerIs Whey Protein Recovery Randomized Trial safe?Whey Protein Recovery Randomized Trial has evidence relevant to safety, limits, and clinician-di...AnswerWhat does the evidence say about Whey Protein Recovery Randomized Trial?Whey Protein Recovery Randomized Trial has evidence relevant to benefits, uncertainty, and pract...AnswerDoes Whey Protein Muscle Recovery Randomized Trial work?Whey Protein Muscle Recovery Randomized Trial has evidence relevant to strength of evidence and...

Source documents

  1. The Impact of Oral Whey Protein and Yeast Protein Supplementation for 6 Months on Skeletal Muscle Mass, Strength, and Function in the Elderly: A Randomized, Controlled, Parallel Study
  2. Resistant Starch as a Functional Nutrient to Control Cardiometabolic Risk Factors in Humans: An Integrative Review